CT2 Lecture Series

CT2 Lecture Series

by CRCERA Editor .

All lectures are on Tuesdays from 12 to 1 p.m. Due to the COVID-19 protocols, all lectures will be delivered online via Zoom until further notice.

For the link and password to join each lecture, please contact Maureen Wade.

Topics in Cancer Drug Development
This is a series of 10 monthly lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.

 

Jukka Westermarck, MD/PhD University of Turku & Åbo Akademi

Oct

27

Tue

PP2A, a druggable tumor suppressor phosphatase for cancer therapy

Dr. Westermarck is Research Director and Professor of Cancer Biology at Turku Bioscience, University of Turku in Helsinki, Finland.

12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.

J. Silvio Gutkind, PhD UCSD Moores Cancer Center, UCSD School of Medicine

Oct

20

Tue

The Hippo and PIK3CA-mTOR Signaling Networks in Cancer: New Multimodal Precision Targeted and Immunotherapies

Dr. Gutkind is Chair of the Department of Pharmacology at UCSD School of Medicine and Associate Director of Basic Science at UCSD Moores Cancer Center

1pm-2pm Lecture *Please note special time!
Contact Maureen Wade for the Zoom link.

Gordon Mills, MD/PhD Oregon Health and Science, Knight Cancer Institute

Oct

13

Tue

Targeting adaptive responses to therapy: PARP inhibitors as a model

Dr. Mills is the Director of Precision Oncology, Knight Cancer Institute and Professor of Cell and Developmental and Cancer Biology

12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.

Jason Sicklick, MD UCSD

Oct

6

Tue

Tyrosine Kinase Inhibition for GIST: Moving Beyond Version 1.0

12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.

Tony Hunter, PhD Salk Institute

Sep

29

Tue

The long road from discovery of tyrosine kinases to more than 50 approved TKIs

Dr. Hunter is the Renato Dulbecco Chair in Cancer Research and Deputy Director of the Salk Institute Cancer Center

12pm-1pm Lecture
Contact Maureen Wade for the Zoom link.

Past Lectures

Lyudmila Bazhenova, MD UCSD

Apr

28

Tue

Lung Cancer 2020

12pm-1pm Lecture

Yuan Chen, PhD UCSD

May

5

Tue

Ubiquitin-like modifications as targets for cancer therapy

12pm-1pm Lecture

Nichol Miller, PhD Pfizer

May

12

Tue

Dr. Miller is a Senior Principal Scientist at Pfizer.

12pm-1pm Lecture

Gen-Sheng Feng, PhD UCSD

Apr

21

Tue

Liver cancer research, from mechanism to diagnosis and therapy

12pm-1pm Lecture

Michael Kalichman, PhD UCSD

Apr

14

Tue

Why do scientists cheat?

12pm-1pm Lecture

Stephen Schoenberger, PhD La Jolla Institute

Apr

7

Tue

Going Natural with Cancer Neoantigens

11:45am Lunch
12pm-1pm Lecture

Peter Zage, MD UCSD

Mar

31

Tue

Using Neuroblastoma Cytogenetics to Identify Novel Therapeutic Targets

11:45am Lunch
12pm-1pm Lecture

Quyen Nguyen, MD/PhD UCSD

Mar

24

Tue

Surgery with fluorescence guided navigation - imaging tumors and nerves

11:45am Lunch
12pm-1pm Lecture

Napoleone Ferrara, MD UCSD

Mar

17

Tue

Developing Novel Protein Therapeutics In An Academic Setting

11:45am Lunch
12-1pm Session

icon 1 icon 1 icon 1

CT2 Program and Lecture Series Faculty Organizer
Michael Bouvet, MD, FACS
Professor of Surgery
Director of Endocrine Surgery
Moores Cancer Center
UC San Diego Medical School

Program Contact: Angela Robles, PhD, angelarobles@health.ucsd.edu

return to top

Newsletter

The CRCERA Newsletter comes once a month and includes a list of the latest training opportunities. Don't miss out - sign up now!

[mc4wp_form id="55"]